Showing results (151-160 of 248) with videos related to
Sort By:
Pageof 25
Vaccine|February 29, 2008
Vaccination with recombinant Mycobacterium avium subsp. paratuberculosis proteins induces differential immune responses and protects calves against infection by oral challengeKumanan Kathaperumal, Sung-Un Park, Sean McDonough, et al.Journal of Autoimmunity|July 2, 2018
TRIF deficiency protects non-obese diabetic mice from type 1 diabetes by modulating the gut microbiota and dendritic cellsElke Gülden, Chen Chao, Ningwen Tai, et al.Immunology|February 18, 2017
Anti-CD3 treatment up-regulates programmed cell death protein-1 expression on activated effector T cells and severely impairs their inflammatory capacityMaja Wallberg, Asha Recino, Jenny Phillips, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 20, 2014
1-Aminobenzotriazole coincubated with (S)-warfarin results in potent inactivation of CYP2C9Jasleen K Sodhi, Kevin A Ford, Sophie Mukadam, et al.Journal of Autoimmunity|June 9, 2017
Nucleotide-binding oligomerization domain-containing protein 2 (Nod2) modulates T1DM susceptibility by gut microbiotaYang-Yang Li, James A Pearson, Chen Chao, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 28, 2009
Inflammatory regulation by TLR3 in acute hepatitisXiaoyan Xiao, Peng Zhao, Daniel Rodriguez-Pinto, et al.Plos One|December 24, 2011
T cells recognizing a peptide contaminant undetectable by mass spectrometryVedran Brezar, Slobodan Culina, Thomas Østerbye, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|February 23, 2020
Targeting proinsulin to local immune cells using an intradermal microneedle delivery system; a potential antigen-specific immunotherapy for type 1 diabetesFarah Arikat, Stephanie J Hanna, Ravinder K Singh, et al.Drug Metabolism Letters|December 15, 2017
Utility of Pooled Cryopreserved Human Enterocytes as an In vitro Model for Assessing Intestinal Clearance and Drug-Drug InteractionsSusan Wong, Utkarsh Doshi, Peter Vuong, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 15, 2012
Preclinical assessment of the absorption and disposition of the phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor GDC-0980 and prediction of its pharmacokinetics and efficacy in humanLaurent Salphati, Jodie Pang, Emile G Plise, et al.Pageof 25